Tyme Technologies Inc
NASDAQ:TYME
Tyme Technologies Inc
Other Current Liabilities
Tyme Technologies Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tyme Technologies Inc
NASDAQ:TYME
|
Other Current Liabilities
$1.9m
|
CAGR 3-Years
38%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Tyme Technologies Inc's Other Current Liabilities?
Other Current Liabilities
1.9m
USD
Based on the financial report for Jun 30, 2022, Tyme Technologies Inc's Other Current Liabilities amounts to 1.9m USD.
What is Tyme Technologies Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
81%
Over the last year, the Other Current Liabilities growth was 149%. The average annual Other Current Liabilities growth rates for Tyme Technologies Inc have been 38% over the past three years , 81% over the past five years .